Phage-Assisted Continuous Evolution (PACE)

Phage-Assisted Continuous Evolution (PACE)

1. Research Background

Protein directed evolution is a key strategy for optimizing protein functions in biotechnology and synthetic biology. Conventional directed evolution approaches (e.g., error-prone PCR, saturation mutagenesis) are limited by long experimental cycles and low screening throughput. Against this background, GeneRulor provides customized services based on the M13 Phage-Assisted Continuous Evolution (PACE) platform.

By leveraging the extremely short life cycle of bacteriophages, this platform integrates protein mutagenesis, screening, and amplification into an automated continuous cyclic system. It can complete evolution tasks within days that previously required months or even years. We are committed to delivering efficient and precise protein engineering solutions for global academic and industrial clients.

2. System Characteristics and Biological Background

(1) Host Strain: The PACE system mainly uses Escherichia coli (E. coli) as the host, enabling rapid protein synthesis supported by its well-characterized genetic background.

(2) Evolution Vector: M13 filamentous phage is employed. A notable feature is its non-lytic life cycle: progeny phages are released via secretion, ensuring stable evolution in a continuously flowing liquid culture system (Lagoon).

(3) Selection Mechanism: The function of the target protein (e.g., binding affinity, catalytic activity) is coupled to the expression of essential phage infection proteins (e.g., pIII). Only mutants with the desired function can generate infectious progeny, achieving “survival of the fittest” under selective pressure.

Figure 1 Schematic diagram of the PACE system operation in the lagoon bioreactor

3. Core Evolution Strategies

To meet the functional engineering requirements of diverse proteins, our mainstream PACE strategies include:

(1) Mutagenesis Plasmid (MP) System: An inducible mutagenesis plasmid is introduced into host cells to drastically increase the mutation rate of phage genomes during replication (100–1000-fold higher than the natural level).

(2) Selection Plasmid (SP) Design: Sophisticated genetic circuits are designed based on target protein properties (e.g., polymerase activity, protease specificity, DNA-binding affinity) to control the transcription of thegIII gene.

(3) Optimized Drift Evolution: For challenging evolution tasks, reduced selection pressure allows mutants to cross “fitness valleys”, enabling breakthrough improvements in performance.

4. Core Application Areas

(1) Enzyme Performance Optimization: Significantly enhance catalytic activity, thermostability, or alter substrate specificity.

(2) Antibody Affinity Maturation: Rapidly isolate monoclonal antibodies or nanobody fragments with ultra-high affinity.

(3) Development of Novel Biosensors: Evolve transcription factors to generate highly sensitive sensing systems for specific small molecules or environmental signals.

(4) Evolution of Gene-Editing Tools: Engineer Cas9, Base Editors, and other effector enzymes to reduce off-target effects or redefine PAM recognition sequences.

5. Project Workflow and Validation

We provide one-stop services from library design to final evolved strain delivery:

(1) Selection Circuit Design: Custom-engineer selection plasmids (SP) tailored to your target protein.

(2) Initiation of Evolution System: Launch continuous evolution in a constant-flow bioreactor.

(3) High-Throughput Identification: Regularly sample and quantify phage titer, and track mutation enrichment via NGS deep sequencing.

Figure 2 Schematic diagram of the project process

6. Core Service Introduction

(1) High-Efficiency Evolution: A single project can cover hundreds of generations of evolutionary cycles, with efficiency far exceeding traditional plate-based screening.

(2) Customized Selection Pressure Regulation: Dynamically adjust dilution rate and inducer concentration according to evolutionary progress, preventing evolutionary dead ends.

(3) Full-Process Validation: Provide kinetic parameter comparisons of protein activity before and after evolution, as well as complete sequence sequencing reports.

(4) Technical Advantages: High throughput, supporting parallel operation of multiple Lagoon reactors for the simultaneous evolution of different protein variants. Seamless transition: Evolved mutants with superior properties can be directly used for subsequent large-scale production and applications.

7. Case Study

Case: Reprogramming the Protease Specificity of Botulinum Neurotoxin via Phage-Assisted Continuous Evolution

Project Content:

Using the phage-assisted continuous evolution (PACE) system, we successfully reprogrammed the protease specificity of botulinum neurotoxin (BoNT) to selectively cleave non-native substrates.

(1) Research Background:

Botulinum neurotoxins (BoNTs) are zinc-dependent metalloproteases produced byClostridium botulinum. Their light chain (LC) domain exhibits high substrate specificity, precisely cleaving SNARE family proteins (e.g., SNAP-25, VAMP), thereby blocking neurotransmitter release. They are widely used in treating muscle spasms and cosmetic applications.

However, the extremely narrow native substrate range of BoNT proteases limits their potential as targeted therapeutic tools. Although previous studies have attempted to expand their substrate specificity through engineering, progress has been limited: BoNT proteases recognize substrates via multiple exosites and conformational changes, making specificity reprogramming highly challenging. Most engineering efforts only achieve minor specificity adjustments (e.g., single amino acid substitutions) and often retain activity toward native substrates.

An efficient evolution platform capable of simultaneous positive selection (promoting cleavage of new substrates) and negative selection (suppressing off-target activity) is required to achieve complete specificity reprogramming. Phage-assisted continuous evolution (PACE) greatly accelerates protein evolution through continuous mutagenesis and selection, providing a critical tool for this study.

(2) Scheme Design:

This study developed a dual-selection PACE system, combining positive and negative selection strategies to reprogram the specificity of BoNT proteases. The core design includes:

PACE System Construction: A protease-activated RNA polymerase (PAP) was used, in which T7 RNA polymerase is fused with the inhibitor T7 lysozyme, and the linker region contains the target substrate sequence. Protease cleavage releases the inhibitor, activating the expression of the gIII gene (essential for phage replication). An off-target substrate sequence was introduced into T7-PAP; cleavage leads to the expression of a dominant-negative pIII variant (pIII-neg), which inhibits phage proliferation. The expression level of pIII-neg was regulated via ribosome binding site (RBS) engineering to control the stringency of selection.

Evolution Strategy: A stepping-stone substrate trajectory was adopted, gradually introducing substrate mutations to reduce the difficulty of evolution. Parallel experiments of PACE (continuous evolution) and PANCE (non-continuous evolution) were performed to balance selection pressure and diversity. Different evolutionary paths were designed for three BoNT proteases (types X, F, and E), targeting new substrates such as Ykt6, VAMP4, VAMP7, and PTEN.

Key Innovations: The dual-selection system achieved simultaneous positive and negative selection for the first time, effectively eliminating off-target activity. Structural analysis (e.g., X-ray crystallography) guided mutation design and revealed the mechanism of specificity changes.

(3) Experimental Conclusions:

Through the PACE system, multiple BoNT protease variants were successfully evolved with significantly altered specificity:

BoNT/X Protease Reprogramming: The Ykt6-selective variant (X(4130)B1) showed a 1.5-fold increase in activity toward Ykt6 and a 700-fold decrease in activity toward VAMP1/2/3, resulting in a total specificity change of 1,060-fold. Crystal structure analysis revealed that the A166E mutation enhances selectivity by electrostatically repelling the negatively charged P3 residue of VAMP1. The VAMP4-selective variant (X(5010)B1) exhibited a 2.5-fold increase in catalytic efficiency (k/K) toward VAMP4 and an 85-fold decrease toward VAMP1, with a total change of 218-fold.

BoNT/F Protease Targeting VAMP7: Variant F(3230)A3 contained 21 mutations, with an ≥18-fold increase in k toward VAMP7 and a 6,800-fold decrease toward VAMP1, resulting in a total specificity change of ≥3.5×10⁵-fold. Mass spectrometry analysis revealed a shift in the cleavage site to E162, contributing to specificity. Reversion mutation experiments showed that specificity is determined by the synergy of multiple mutations, with no single key mutation.

BoNT/E Protease Targeting Non-SNARE Protein PTEN: Variant E(4130)A2 contained 16 mutations, with a >18,300-fold increase in k toward PTEN and a 606-fold decrease toward SNAP-25, resulting in a total specificity change of ≥1.1×10⁷-fold. This is the first report of a BoNT protease successfully cleaving a non-SNARE substrate. In neuronal experiments, the variant fused with a membrane-localization domain (PH) effectively cleaved endogenous PTEN without off-target activity toward natural substrates such as SNAP-25.

Functional Validation: The evolved proteases could assemble into holotoxins, be delivered to the neuronal cytoplasm via the BoNT heavy chain, and retain cleavage activity. Crystal structure analysis (e.g., BoNT/X variants) showed that active site mutations (e.g., A166E) regulate substrate recognition through electrostatic interactions.

(4) Application Significance:

Technical Platform Value: The dual-selection PACE system provides a universal and efficient platform for protease reprogramming, which can be extended to other protease families. The platform supports complex specificity engineering, solving the problem of substrate promiscuity commonly encountered in traditional directed evolution.

Therapeutic Potential: Evolved proteases can target disease-related proteins (e.g., the role of PTEN in neural regeneration), providing new tools for precision therapy. The self-delivery capability of BoNT makes it an ideal carrier for delivering targeted proteases to specific cell types.

Scientific Insights: It reveals the evolutionary plasticity of BoNT proteases: despite their high natural specificity, their substrate recognition interface can be significantly reprogrammed through mutations. Mutation hotspots (e.g., the 164-168 region of BoNT/F) provide guidance for subsequent engineering.

Future Directions: Combine BoNT heavy chain engineering to achieve tissue-specific delivery. Extend to other pathogen proteases or custom enzyme tools for basic research and biotechnology.

8. References

[1] Esvelt, K. M., et al. (2011). A system for the continuous directed evolution of biomolecules. Nature.

[2] Badran, A. H., & Liu, D. R. (2015). In vivo continuous directed evolution. Current Opinion in Chemical Biology.

[3] Packer, M. S., & Liu, D. R. (2015). Methods for the directed evolution of proteins. Nature Reviews Genetics.

[4] Blum, T. R., et al. (2021). Phage-assisted evolution of botulinum neurotoxin proteases with reprogrammed specificity. Science.

Cooperate With Us

By choosing us, you will gain a highly experienced and technically competent partner in gene editing. We are committed to accelerating your research and projects with professional expertise, rigorous protocols, and efficient communication.

Consult now to get your customized gene editing strategy and quotation!